Skip to content

Public FDA record

Z-2188-2021: HeartWare HVAD Pump Implant Kit, REF 1103

Recall record Z-2188-2021 for Heartware, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2188-2021
Company in FDA record
Heartware, Inc.
FDA record creation date
Aug 6, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Medtronic is stopping the distribution and sale of the HVAD System due to a growing body of observational clinical comparisons that shows a higher frequency of neurological adverse events and mortality associated with the system when compared to other commercially available left ventricular assist devices, as well as complaints that the internal pump may delay or fail to restart.

Source facts

Action
In the United States, beginning 03-Jun-2021, this notice was delivered to Risk Managers via UPS 2-day delivery in the United States as well as through verbal and in person follow ups from the Medtronic field staff. In addition, a courtesy copy was sent to all implanting and following physicians via UPS 2-day delivery. Finally, an e-mail notice was sent as a courtesy copy to all consignees who had opted into communication from Medtronic. Medtronic began an additional communication on 7 July 2021 to all consignees who, according to Medtronic records had unexpired product (see Attachment D Product List) at the time of the initial communication on 03-JUN-2021. The consignees are being asked to confirm receipt of the notification and return all affected product within their possession. This communication also stresses the importance of not returning peripherals (batteries, cables, patient packs, etc.) and surgical tool kits if they still have patients on support. In the US, this communication was delivered to VAD Coordinators via UPS 2-day delivery. Outside of the United States, beginning 07-JUL-2021 this communication will be delivered to consignees.
Initiated
2021-06-03
Root cause
Unknown/Undetermined by firm
Distribution
Worldwide distribution. US nationwide and Armenia, AUSTRIA, Bahrain, Belgium, CROATIA, CZECH REPUBLIC, Denmark, EGYPT, ESTONIA, FINLAND, FRANCE, GERMANY, GREECE, Hungary, Israel, ITALY, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, LITHUANIA, LUXEMBOURG, Macedonia, NETHERLANDS, Norway, POLAND, Qatar, Romania, SAUDI ARABIA, Serbia, Slovakia, SOUTH AFRICA, Spain, Sweden, SWITZERLAND, TAIWAN, Turkey, Ukraine, UNITED ARAB EMIRATES, and United Kingdom.
Recall number
Z-2188-2021
Recall status
Open, Classified
CDRH record ID
188067
FDA record created
2021-08-06
Recall event number
88197

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗